Use of Nucleic Acid Tests on Pooled and Individual Samples From Donors of Whole Blood and Blood Components, Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus: Final Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 1, 2012
June 15, 2019
e8fb757d-ba0b-4dd1-9173-494e61da9b48
Related Documents
Clinical Considerations for Therapeutic Cancer Vaccines: Guidance for Industry
Guidance DocumentOctober 1, 2011Center for Biologics Evaluation and Research
Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion: Guidance for Industry
Guidance DocumentNovember 6, 2009Center for Biologics Evaluation and Research
Nucleic Acid Testing to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products: Guidance for Industry
Guidance DocumentJuly 28, 2009Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.